These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3067713)

  • 1. Cyto-immunologic monitoring following heart transplantation.
    Wijngaard PL; Heyn A; van der Meulen A; de Vries H
    Bibl Cardiol; 1988; (43):137-41. PubMed ID: 3067713
    [No Abstract]   [Full Text] [Related]  

  • 2. Noninvasive patient control after heart transplantation. A 6-year experience at the Munich University Hospital.
    Kemkes BM; Angermann C; Haberl R; Reichenspurner H; Klanke D; Anthuber M; Gokel M
    Bibl Cardiol; 1988; (43):119-27. PubMed ID: 3067710
    [No Abstract]   [Full Text] [Related]  

  • 3. The diagnosis of acute cardiac rejection by endomyocardial biopsy.
    Billingham ME
    Bibl Cardiol; 1988; (43):83-102. PubMed ID: 3067725
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of beta 2-microglobulin in the monitoring of patients after orthotopic heart transplantation.
    Prischl F; Teufelsbauer H; Havel M; Laczkovics A; Wolner E; Schwarzmeier J
    Bibl Cardiol; 1988; (43):111-5. PubMed ID: 3067708
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitoring of cardiac transplants with beta 2-microglobulin, cytoimmunological monitoring and endmyocardial biopsy: what's their value in detecting rejection?
    Semik M; Konertz W; Westphal E; Heusermann U; Friedl A; Bernhard A
    Bibl Cardiol; 1988; (43):133-6. PubMed ID: 3067712
    [No Abstract]   [Full Text] [Related]  

  • 6. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endomyocardial biopsy following heart transplantation: results and complications].
    Furrer M; Schneider K; Gallino A; Schneider J; Vogt P; Turina M
    Helv Chir Acta; 1989 Jan; 55(5):629-32. PubMed ID: 2654093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoimmunological monitoring to detect rejection after heart transplantation.
    Jutte NH; Daane R; van den Bemd JM; Hop WC; Essed CE; Simoons ML; Bos E; Weimar W
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2519-20. PubMed ID: 2650319
    [No Abstract]   [Full Text] [Related]  

  • 9. [Noninvasive monitoring of rejection in heart transplant patients. An overview of current status and use at a small transplant center].
    Wasler A; Petutschnigg B; Iberer F; Auer T; Tscheliessnigg KH
    Wien Klin Wochenschr; 1991; 103(4):105-10. PubMed ID: 2042368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoimmunologic monitoring for the diagnosis of acute rejection after heart transplantation.
    Wijngaard PL; van der Meulen A; Schuurman HJ; Gmelig Meyling FH; Heyn A; Borleffs JC; Jambroes G
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2521-2. PubMed ID: 2650320
    [No Abstract]   [Full Text] [Related]  

  • 11. Session VI: Rejection/infection: the limits of heart transplantation success.
    Behrendt DM; Billingham ME; Boucek MM; Marxmiller JM; Rose EA; Marcelletti C
    J Heart Lung Transplant; 1991; 10(5 Pt 2):841-7. PubMed ID: 1742296
    [No Abstract]   [Full Text] [Related]  

  • 12. Reproducibility and reliability of cytoimmunological monitoring (CIM) of heart transplanted patients (HTP).
    Klanke D; Hammer C; Schübel C; Caca C; Dirschedl P; Gokel M; Kemkes BM
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2512-3. PubMed ID: 2650316
    [No Abstract]   [Full Text] [Related]  

  • 13. Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients.
    van Gelder T; Mulder AH; Balk AH; Mochtar B; Hesse CJ; Baan CC; Vaessen LM; Weimar W
    J Heart Lung Transplant; 1995; 14(2):346-50. PubMed ID: 7779855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic-cytologic monitoring of heart transplant patients].
    Hammer C
    Z Kardiol; 1986; 75 Suppl 5():121-3. PubMed ID: 3548117
    [No Abstract]   [Full Text] [Related]  

  • 15. Utility of surveillance biopsies in infant heart transplant recipients.
    Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart transplantation: life-long biopsies for prevention of rejection?].
    Stallmach T; Gaspert A; Ersch J; Oechslin E
    Schweiz Med Wochenschr; 2000 Jun; 130(25):957-62. PubMed ID: 10909723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complications of endocardial biopsy in heart transplant patients].
    Uchida N; Mukai S; Wada S; Mitsui N; Sueda T; Matsuura Y; Hirai S; Baudet E
    Kyobu Geka; 1995 Jul; 48(7):557-9. PubMed ID: 7637221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The transplanted heart. Morphologic findings in endomyocardial biopsies (EMCB)].
    Frenzel H; Huth F
    Z Kardiol; 1986; 75 Suppl 5():115-9. PubMed ID: 3548116
    [No Abstract]   [Full Text] [Related]  

  • 19. Reliability and usefulness of immunofluorescence in heart transplantation.
    Bonnaud EN; Lewis NP; Masek MA; Billingham ME
    J Heart Lung Transplant; 1995; 14(1 Pt 1):163-71. PubMed ID: 7727465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of endomyocardial biopsy in the diagnosis of lymphoproliferative disorder after heart transplantation.
    Fernández-González AL; Herreros-González JM; Pardo Mindán J
    J Heart Lung Transplant; 1994; 13(6):1146. PubMed ID: 7865524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.